144 related articles for article (PubMed ID: 19804500)
1. Hepatitis C virus NS4 protein impairs the Th1 polarization of immature dendritic cells.
Takaki A; Tatsukawa M; Iwasaki Y; Koike K; Noguchi Y; Shiraha H; Sakaguchi K; Nakayama E; Yamamoto K
J Viral Hepat; 2010 Aug; 17(8):555-62. PubMed ID: 19804500
[TBL] [Abstract][Full Text] [Related]
2. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
Brady MT; MacDonald AJ; Rowan AG; Mills KH
Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
5. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
[TBL] [Abstract][Full Text] [Related]
7. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.
Kanto T; Hayashi N; Takehara T; Tatsumi T; Kuzushita N; Ito A; Sasaki Y; Kasahara A; Hori M
J Immunol; 1999 May; 162(9):5584-91. PubMed ID: 10228041
[TBL] [Abstract][Full Text] [Related]
8. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C.
Murakami H; Akbar SM; Matsui H; Horiike N; Onji M
Clin Exp Immunol; 2004 Sep; 137(3):559-65. PubMed ID: 15320906
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.
Rowan AG; Fletcher JM; Ryan EJ; Moran B; Hegarty JE; O'Farrelly C; Mills KH
J Immunol; 2008 Oct; 181(7):4485-94. PubMed ID: 18802051
[TBL] [Abstract][Full Text] [Related]
12. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
13. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
14. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
[TBL] [Abstract][Full Text] [Related]
16. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
[TBL] [Abstract][Full Text] [Related]
17. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
[TBL] [Abstract][Full Text] [Related]
18. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.
Wang JH; Layden TJ; Eckels DD
Hum Immunol; 2003 Jul; 64(7):662-73. PubMed ID: 12826368
[TBL] [Abstract][Full Text] [Related]
20. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
